OMC
CNTA

OUP Management Company’s Centessa Pharmaceuticals CNTA Stock Holding History

OUP Management Company’s Portfolio CNTA Stock Details CNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$19M Hold
2,937,615
– – 42.74% 1
2023
Q2 		$18.2M Hold
2,937,615
– – 31.01% 1
2023
Q1 		$11.3M Hold
2,937,615
– – 22.57% 2
2022
Q4 		$9.11M Hold
2,937,615
– – 14.87% 2
2022
Q3 		$11.8M Hold
2,937,615
– – 18.39% 1
2022
Q2 		$14.3M Hold
2,937,615
– – 19.69% 1
2022
Q1 		$26.4M Buy
2,937,615
+595,724
+25% +$5.43M 20.06% 2
2021
Q4 		$26.4M Buy
+2,341,891
New +$31.5M 11.89% 3

Other funds holding CNTA

MVM
Medicxi Ventures Management St. Helier, Jersey $982M AUM 210.17% 1-Year Est. Return
GA
General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.34B AUM 204.53% 1-Year Est. Return
VVA
Vida Ventures Advisors Boston, Massachusetts $29.4M AUM 93.58% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $57.5B AUM 55.25% 1-Year Est. Return